- Home
- SATX vs RCEL Comparison
SATX vs RCEL Comparison
Compare SATX & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SATX
- RCEL
- Stock Information
- Founded
- SATX 2012
- RCEL N/A
- Country
- SATX Israel
- RCEL United States
- Employees
- SATX N/A
- RCEL N/A
- Industry
- SATX Radio And Television Broadcasting And Communications Equipment
- RCEL Medical/Dental Instruments
- Sector
- SATX Technology
- RCEL Health Care
- Exchange
- SATX Nasdaq
- RCEL Nasdaq
- Market Cap
- SATX 175.9M
- RCEL 170.8M
- IPO Year
- SATX N/A
- RCEL N/A
- Fundamental
- Price
- SATX $2.90
- RCEL $5.62
- Analyst Decision
- SATX Strong Buy
- RCEL Strong Buy
- Analyst Count
- SATX 2
- RCEL 4
- Target Price
- SATX $2.25
- RCEL $17.25
- AVG Volume (30 Days)
- SATX 718.8K
- RCEL 347.9K
- Earning Date
- SATX 05-22-2025
- RCEL 05-08-2025
- Dividend Yield
- SATX N/A
- RCEL N/A
- EPS Growth
- SATX N/A
- RCEL N/A
- EPS
- SATX N/A
- RCEL N/A
- Revenue
- SATX $23,654,000.00
- RCEL $71,661,000.00
- Revenue This Year
- SATX $50.67
- RCEL $59.50
- Revenue Next Year
- SATX $1.64
- RCEL $28.89
- P/E Ratio
- SATX N/A
- RCEL N/A
- Revenue Growth
- SATX 130.79
- RCEL 41.35
- 52 Week Low
- SATX $0.58
- RCEL $5.46
- 52 Week High
- SATX $2.97
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- SATX 87.38
- RCEL 25.54
- Support Level
- SATX $2.87
- RCEL $6.06
- Resistance Level
- SATX $2.92
- RCEL $6.38
- Average True Range (ATR)
- SATX 0.03
- RCEL 0.47
- MACD
- SATX 0.05
- RCEL -0.11
- Stochastic Oscillator
- SATX 92.47
- RCEL 8.12
About SATX SatixFy Communications Ltd.
SatixFy Communications Ltd is engaged in developing end-to-end next-generation satellite communication systems. This includes satellite payloads, user terminals, and modems, which are built on powerful in-house designed chipsets. Their products feature modems equipped with Software Defined Radio and Fully Electronically Steered Multi Beam Antennas that support the entire DVB-RCS2 / DVB-S2X industry standards as well as a complete SDR for any other waveform. The company has a geographical presence in the U.S. & Canada, the UK, and Other countries, with the majority of its revenue generated from the U.S. and Canada.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.